Icagen, Inc. To Present At The UBS Warburg Global Specialty Pharmaceuticals Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--April 21, 2006--Icagen, Inc. (NASDAQ: ICGN - News) today announced that P. Kay Wagoner, Ph.D., Chief Executive Officer, will present at the UBS Global Specialty Pharmaceuticals Conference at the Grand Hyatt Hotel in New York City on Monday April 24th at 8:30 a.m. ET. The presentation webcast and accompanying slides will be available on Icagen's website at www.icagen.com.

Back to news